Product Information
DRONABINOL 10 MG CAPSULE is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $4.9213 per EA under NDC 42858086906. Its NADAC has been published 373 times since Nov 14, 2018.
FDA first approved this application on Jun 27, 2008.
Strength
10 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858086906
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
DRONABINOLApproval Type
Generic (ANDA)
FDA Application
ANDA078292FDA Approved
6/27/2008
On Market Since
6/26/2018
Pharmacological Classes
Price Statistics
The NADAC for DRONABINOL 10 MG CAPSULE has been published 373 times since Nov 14, 2018, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9213 per EA |
|---|---|
| All-time high | $7.0843 (Mar 13, 2019) |
| All-time low | $2.9105 (Jan 20, 2021) |
| 52-week high | $4.9971 |
| 52-week low | $4.9213 |
| Median price | $4.2089 |
| Average price | $4.4274 |
| Largest weekly change | +42.2% (Nov 17, 2021) |
| Weeks tracked | 373 |
| Tracking since | Nov 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-1.5%
3Y
+22.1%
5Y
+15.5%
All
-30.4%
Last surveyed Dec 31, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DRONABINOL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rhodes Pharmaceuticals L.P. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DRONABINOL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cannabinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DRONABINOL 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DRONABINOL 10 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $4.9213 per EA (NDC 42858086906), effective Dec 31, 2025.
How has the price of DRONABINOL 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DRONABINOL 10 MG CAPSULE has declined 30.4%. It has been tracked across 373 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for DRONABINOL 10 MG CAPSULE?
Since Nov 14, 2018, the NADAC for DRONABINOL 10 MG CAPSULE has ranged from a low of $2.9105 (Jan 20, 2021) to a high of $7.0843 (Mar 13, 2019), with a median of $4.2089 per EA.
Are there cheaper alternatives to DRONABINOL 10 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of DRONABINOL 10 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DRONABINOL 10 MG CAPSULE?
DRONABINOL 10 MG CAPSULE (NDC 42858086906) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.